Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Novel avenues of action for a hallmark disordered protein of Parkinson's disease

Descripción del proyecto

Información molecular de la fisiopatología de la enfermedad de Parkinson

La enfermedad de Parkinson es un trastorno neurodegenerativo asociado con temblores y una pérdida progresiva de la movilidad. La característica distintiva de la enfermedad es la formación de agregados de la proteína alfa-sinucleína en cuerpos de inclusión conocidos como cuerpos de Lewy. El proyecto financiado con fondos europeos SYN-CHARGE pretende definir el mecanismo que subyace a la toxicidad de estos agregados de proteínas. Los investigadores estudiarán la interacción de la alfa-sinucleína con otras proteínas neuronales y ofrecerán información fundamental sobre la fisiopatología de la enfermedad de Parkinson. Los resultados podrían conducir a nuevas dianas moleculares para el diseño de intervenciones terapéuticas novedosas.

Objetivo

Alpha-synuclein (aSN) is an intrinsically disordered protein (IDP) expressed by neurons, and well-known to aggregate in so-called Lewy bodies (LB) that are a hallmark of Parkinson’s disease (PD) and other LB disorders. Despite extensive research, the mechanisms underlying its toxicity in these disorders still remains to be understood. In this project, I will determine whether aSN can interact with other disordered proteins in a novel, mean-field type interaction, focusing on the disordered loop of the neuronal plasma membrane Ca2+ ATPase (PMCA). I will study this using biophysical techniques, in particular NMR, ITC and SAXS/SANS. This project will improve the understanding of aSN and its interactions and has the potential to pave the way for new discoveries, especially in drug design. I will gain important experience in project design and management, a research network in Europe, and take a significant step towards independence. I will undertake this project at the University of Copenhagen in the research group of Professor Birthe B. Kragelund, an expert in the field of IDP research. The Kragelund group has recently joined the BRAINSTRUC Consortium: a group of researchers working on the structural characterization of neuronal proteins. Thus, they required a postdoctoral researcher with a strong background in neuroscience and structural biology. I was uniquely qualified to take this position as I have been working on neurodegenerative proteins for several years and structurally characterized the IDP associated with Huntington’s disease. Professor Kragelund has experience supervising productive postdoctoral researchers, an extensive European network, and has access to the state-of-the-art facilities necessary to complete this project. I have recently acquired preliminary data to indicate that the two proteins (aSN and PMCA) interact directly. This project has the potential to change how we understand proteins associated with neurodegeneration and their interactions.

Ámbito científico

CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.

Coordinador

KOBENHAVNS UNIVERSITET
Aportación neta de la UEn
€ 219 312,00
Dirección
NORREGADE 10
1165 Kobenhavn
Dinamarca

Ver en el mapa

Región
Danmark Hovedstaden Byen København
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 219 312,00